Extract from Previous Activities
04/2025 – 10/2025Pharmaceutical Company, Germany
Marketing Manager Hepatology (via K-Recruiting)
Strategic and tactical support for differentiation vs. new competitor
Development and roll out of adjusted claims and respective detailing material
Brand plan creation
OPEX planning and expenditure control
03/2025 – 06/2025Pharmaceutical Company, Germany
Marketing Manager Rare Diseases
2024 Pharmaceutical Company, Germany
Marketing Manager Schizophrenia
Onboarding + developing Junior PM
Congress organization (DGPPN)
Brand Plan creation and tactical roll-out
DMI planning
2022 – 2024Pharmaceutical Company, Germany
Marketing Manager Hematology
Repositioned ITP therapy in a competitive market to reverse sales decline
Built a national multi-channel HCP engagement and training campaign
Managed Sales Force onboarding, brand planning, forecasting, and tactical execution
2021 – 2023Pharmaceutical Company, Germany
Marketing Manager
Led launch of an orphan drug for Hereditary Angioedema (HAE) in Germany
Designed and implemented patient communication strategies based on social listening
Developed website and social media campaign recognized as “Best Communication Project 2022” (ex-US)
2021 – 2022Pharmaceutical Company, Germany
Marketing Manager
Developed and launched patient identification campaigns for AHP, PH1, aTTPR using multichannel approaches
Increased diagnostic rates and market engagement in rare disease patient populations
2019 – 2021Pharmaceutical Company, Germany
Patient Support Manager
Served as Patient Support Manager for IBD (Entyvio), contributing to DIGA and device strategy
Served as marketing Manager for Natpar (hypoparathyroidism) and Revestiv (short bowel syndrome)
2015 – 2017Pharmaceutical Company, Germany
Global Head of Marketing
Led pan-European launch of antifungal therapy in hematology hospitals
Delivered launches in 6 key markets, exceeded sales targets by 25–28%
Managed 4 direct reports and cross-functional collaboration
2013 – 2015Pharmaceutical Company, Germany
International Marketing Manager
Pan EU reactivation of 2 key brands: Polyvalent immunoglobins used in CMV infections (CMVIG) and Hepatitis B infections (HBIG)
In collaboration with country teams developing European product strategies and rolling out the respective activities
Growth rates in CMVIG: 30%, in HBIG: 18%
2004 – 2012Pharmaceutical Company, Germany
Regional Marketing Director
Led marketing strategy for anti-infectives across EMEA emerging markets (India, Russia, Turkey)
Built hospital business from around €15M to over €50M in Germany
Implemented MSL structure, KOL-Management, digital detailing, and PR campaigns